New
Advancing Patient Care: VRF Backs Transformative Dermatology Research
We proudly support Dr. John Barbieri's proposal, "Incorporating Patient Preferences into Health Outcome Assessment for Economic Evaluation in Chronic Skin Disease: The Skindex-Utility Index." This project aims to develop a specialized health utility measure for dermatology, with a focus on vitiligo therapies' impact on patients' well-being. Stay tuned for updates as we advance patient care through this transformative research.
FAQOther Questions
- What's the status with official recognition of World Vitiligo Day?
In 2016, the United Nations marked World Vitiligo Day in its International Calendar of Disability Events. However, it was removed in 2019 when the calendar was streamlined to 'M...
- What joining a clinical trial actually looks like?
Pediatric vitiligo trials · Taking part Cream twice a day, scheduled visits and the practical questions every mother asks before committing the family calendar. The studies disc...
- How long does it take to treat vitiligo?
Vitiligo, a condition characterized by the loss of skin pigment, can be unpredictable in both progression and treatment. The time it takes to treat vitiligo varies significantly...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.